Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
DCVC Opportunity Fund II GP, LLC (CIK 1668343) reported $13.9M across 2 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: RXRX ($12.1M, 87.48%), IONQ ($1.7M, 12.52%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RXRX | Recursion Pharmaceuticals, Inc. | $12.1M | 87.48% | 4.0M | Hold |
| 2 | IONQ | IonQ, Inc. | $1.7M | 12.52% | 60,226 | Added |
Source: SEC Form 13F filings · as of 2026-03-31